Nanobiotix (NBTX) Market Cap to FCF (2020 - 2026)

Nanobiotix (NBTX) Market Cap to FCF (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Market Cap to FCF
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -857,493.18
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -49,404.47
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -92,993.30
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 378.74
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 32.83
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 16.92
7 Belite Bio 62.72 Bn 62.72 Bn - -6,039.19
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -34.86
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn 57.96

Historic Data

Download Data
DateValue
Jul 23, 2026 -49,404.47
Jul 22, 2026 -50,326.76
Jul 21, 2026 -49,130.28
Jul 20, 2026 -44,531.33
Jul 17, 2026 -47,098.77
Jul 16, 2026 -46,774.72
Jul 15, 2026 -49,803.30
Jul 14, 2026 -51,897.13
Jul 13, 2026 -48,793.77
Jul 10, 2026 -49,940.39
Jul 9, 2026 -48,544.51
Jul 8, 2026 -48,357.56
Jul 7, 2026 -48,357.56
Jul 6, 2026 -51,224.11
Jul 2, 2026 -47,859.03
Jul 1, 2026 -49,205.06
Jun 30, 2026 -46,986.60
Jun 29, 2026 -44,817.98
Jun 26, 2026 -44,855.38
Jun 25, 2026 -42,911.10